Article Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Categories
Browse Drugs
Browse Journals
Search
Browse Categories
Browse Categories
Allergy and Immunology
Cardiology
Clinical Procedures
Critical Care
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genomic Medicine
Hematology
Infectious Diseases
Nephrology
Neurology
Obstetrics and Gynecology
Oncology
Pathology
Perioperative Care
Physical & Rehabilitation
Psychiatry
Pulmonology
Radiology
Rheumatology
Sports Medicine
Browse Journals
Publications by authors named "Amy Lauren Cummings"
Page
1
of
1
KEYNOTE-042 rolls back programmed cell death ligand 1 threshold for non-small cell lung cancer pembrolizumab monotherapy without new insight into those deriving benefit.
Amy Lauren Cummings
Edward B Garon
Transl Lung Cancer Res
December 2019
View Article and Find Full Text PDF
KEYNOTE-021 cohorts D and H suggest modest benefit in combining ipilimumab with pembrolizumab in second-line or later advanced non-small cell lung cancer treatment.
Amy Lauren Cummings
Kate M Santoso
Jonathan W Goldman
Transl Lung Cancer Res
October 2019
View Article and Find Full Text PDF
Privacy Policy
Site Map
Contact Us
© LitMetric 2025. All rights reserved.
